Literature DB >> 4633171

Suppression of pigmentation in mouse melanoma cells by 5-bromodeoxyuridine: effects on tyrosinase activity and melanosome formation.

J R Wrathall, C Oliver, S Silagi, E Essner.   

Abstract

Low concentrations (1-3 microg/ml) of 5-bromodeoxyuridine (BrdU) reversibly suppress pigmentation in a highly pigmented clone (B(5)59) of cultured B16 mouse melanoma cells. We have found that unpigmented cells (clone C(3)471), derived by long-term culture of B(5)59 cells in 1 microg of BrdU/ml, were completely amelanotic with no biochemically or cytochemically detectable tyrosinase activity or ultrastructural evidence of premelanosomes. The process by which pigmentation is suppressed was studied in B(5)59 cells during a 7-day period of growth with BrdU (3 microg/ml). Assays of tyrosinase activity showed that activity was reduced after 1 day and decreased progressively, approaching zero by 7 days. A quantitatively minor part of this reduction was directly attributable to the appearance of a dialyzable inhibitor of tyrosinase activity. Acrylamide gel electrophoresis revealed two bands of activity corresponding in Rx values to the T(1) and T(2) forms of soluble tyrosinase. Both were progressively reduced during growth with BrdU but one form (T(1)) was consistently affected earlier than the other (T(2)). Ultrastructural-cytochemical studies also showed an early effect on the localization of tyrosinase reaction product. At day 3, reaction product was no longer present in Golgi saccules and Golgi-associated smooth surfaced tubules, but was still seen within premelanosomes, compound melanosomes, and occasional Golgi-associated vesicles. By 7 days tyrosinase reaction product was usually not demonstrable. The number of premelanosomes was progressively decreased during growth with BrdU. Premelanosomes became concentrated in the juxtanuclear region and at day 3 many were contained within abnormally large and numerous compound melanosomes. Premelanosomes and compound melanosomes were rarely seen at 7 days, by which time the cultures were nearly amelanotic. The coordinated suppression of melanogenesis by BrdU may provide a useful model in which to study the normal regulation of this process.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4633171      PMCID: PMC2108968          DOI: 10.1083/jcb.57.2.406

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  38 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Separation and characterization of multiple forms of tyrosinase from mouse melanoma.

Authors:  J B Burnett; H Seiler; I V Brown
Journal:  Cancer Res       Date:  1967-05       Impact factor: 12.701

3.  Multiple forms of tyrosinase from human melanoma.

Authors:  J B Burnett; H Seiler
Journal:  J Invest Dermatol       Date:  1969-02       Impact factor: 8.551

4.  Modification of malignancy by 5-bromodeoxyuridine. Studies of reversibility and immunological effects.

Authors:  S Silagi
Journal:  In Vitro       Date:  1971 Sep-Oct

5.  Regulation of melanin synthesis in mammalian cells, as studied by somatic hybridization. II. The level of regulation of 3,4-dihydroxyphenylalanine oxidase.

Authors:  R Davidson; K Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

6.  Sulfhydryl content in subcellular fractions of mouse melanomas.

Authors:  M Seiji; T Yoshida; T Sakurane; R Ogura
Journal:  J Invest Dermatol       Date:  1967-03       Impact factor: 8.551

7.  Tyrosinase inhibitor in Fortner's amelanotic and melanotic malignant melanoma.

Authors:  G J Satoh; Y Mishima
Journal:  J Invest Dermatol       Date:  1967-04       Impact factor: 8.551

8.  Genetic regulation of multiple forms of tyrosinase in mice: action of a an b loci.

Authors:  T J Holstein; J B Burnett; W C Quevedo
Journal:  Proc Soc Exp Biol Med       Date:  1967-11

9.  Tumorigenicity, immunogenicity, and virus production in mouse melanoma cells treated with 5-bromodeoxyuridine.

Authors:  S Silagi; D Beju; J Wrathall; E Deharven
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

10.  Tyrosinase inhibition: its role in suntanning and in albinism.

Authors:  L T Chian; G F Wilgram
Journal:  Science       Date:  1967-01-13       Impact factor: 47.728

View more
  12 in total

1.  Suppressive effect of spinach extract on the formation of melanin in B16 mouse melanoma cells.

Authors:  M Kobori; Y Sasaki; K Shinohara
Journal:  Cytotechnology       Date:  1994-01       Impact factor: 2.058

2.  Sister chromatid differential staining and NOR activity of BrdU-resistant sublines.

Authors:  Y Yongshan; Q Jin; X Xiahui
Journal:  Theor Appl Genet       Date:  1985-08       Impact factor: 5.699

3.  Hormone regulation of development in plant cells.

Authors:  T L Shininger
Journal:  In Vitro       Date:  1978-01

4.  Deoxycytidine reverses the suppression of nucleolar organizer regions' activity caused by BrdU.

Authors:  Y Yongshan; Q Jin; X Xiahui
Journal:  Theor Appl Genet       Date:  1984-05       Impact factor: 5.699

5.  Effect of 5-bromo-2'-deoxyuridine on growth and differentiation of cultured embryonic retinal pigment cells.

Authors:  R I Garcia; I Werner; G Szabo
Journal:  In Vitro       Date:  1979-10

6.  Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells.

Authors:  J K Christman; S Silagi; E W Newcomb; S C Silverstein; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

7.  Embryonic and postnatal injections of bromodeoxyuridine produce age-dependent morphological and behavioral abnormalities.

Authors:  B Kolb; B Pedersen; M Ballermann; R Gibb; I Q Whishaw
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

8.  Reversible suppression of malignancy and differentiation of melanoma cells.

Authors:  S Silagi
Journal:  Am J Pathol       Date:  1977-12       Impact factor: 4.307

9.  Cell type conversion in a mouse melanoma cell clone.

Authors:  S Sato; T Takeuchi
Journal:  In Vitro       Date:  1982-08

Review 10.  The natural history of a family of transplantable melanomas in hamsters.

Authors:  A Bomirski; A Słominski; J Bigda
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.